We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App





At Least One Effective COVID-19 Vaccine to Be Available by 2021, But Only in Limited Quantities, Says WHO

By HospiMedica International staff writers
Posted on 16 Oct 2020
There would be at least one safe and effective COVID-19 vaccine by 2021, although it will be available in “limited quantities” which may require priority to be given to vulnerable people and result in a delay in the immunization of healthy, young people until 2022.

The World Health Organization’s (WHO Geneva, Switzerland) chief scientist, Dr. More...
Soumya Swaminathan, has warned that young and healthy people should be prepared to wait for immunization for well over a year. Speaking at a WHO social media event, Dr. Swaminathan said that despite the global efforts for developing a COVID-19 vaccine and several candidates undergoing clinical trials, speedy and mass inoculation was highly unlikely. Health-care workers and others on the front lines would be the first ones to receive a COVID-19 vaccine, followed by the elderly or sick. The WHO would work along with governments and international organizations to ensure that the people facing the highest risk receive priority for the vaccine. This means that the remaining young population who are in sound health would have to wait longer to be vaccinated.

“Most people agree, it’s starting with health care workers, and front-line workers, but even there, you need to define which of them are at highest risk, and then the elderly, and so on,” said Dr. Swaminathan. “There will be a lot of guidance coming out, but I think an average person, a healthy young person might have to wait until 2022 to get a vaccine.”

Separately, Robin Nandy, the chief of immunization at UNICEF, said in an interview that COVID-19 vaccines would be initially available only in small quantities that would be insufficient to vaccinate the world’s entire population.

“Vaccines are going to be available in the initial years in too small quantities to vaccinate the seven billion people we have across the globe today,” Robin Nandy, the chief of immunization at UNICEF, said in an interview. “Vaccines will arrive in dribs and drabs.”

People providing essential services such as health care and education should be among the first to be vaccinated, he said. “We have to live with the pandemic for a while, so we need these systems to continue."

Related Links:
World Health Organization


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
X-Ray Generator
Advantage Plus Generators
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.